[Comparison of oral diazoxide and minoxidil in refractory hypertension]
- PMID: 7442081
- DOI: 10.1007/BF01478605
[Comparison of oral diazoxide and minoxidil in refractory hypertension]
Abstract
The efficacy and side effects of two potent vasodilatators, namely diazoxide and minoxidil given orally, were compared in 11 patients who had hypertension refractory to conventional drug treatment. The latter included diuretics, betablockers and/or sympatholytics, and either dihydralazine or prazosin. In a crossover approach, dihydralazine and prazosin were withdrawn and replaced by diazoxide or minoxidil. In nine patients the diazoxide phase preceded the minoxidil treatment, while in two it followed minoxidil treatment. Before introduction of the more potent vasodilators blood pressure averaged 181/107 mm Hg in the supine and 161/103 mm Hg in the upright position. Both, oral diazoxide (median dose 400 mg/d( and minoxidil (medium dose 17.5 mg/d) produced similar decreases (p < 0.02) in mean arterial pressure (-15%) in the supine and (-11 vs. -12%) in the upright position. They caused a comparable tendency for sodium retention and weight gain which could be satisfactorily controlled with increased diuretic therapy, except in one patient. Hypertrichosis occurred with both drugs, but tended to be somewhat milder with diazoxide. Electrocardiograms remained generally unchanged. Plasma glucose levels were increased during diazoxide treatment in six patients necessitating interruption of this therapy in four patients. It is concluded that the antihypertensive potency and most side effect of orally administered diazoxide are comparable to those of minoxidil, except for diazoxide-related hyperglycemia which may limit the use of this substance.
Similar articles
-
Comparative evaluation of the new vasodilator carprazidil and minoxidil in the treatment of moderate to severe hypertension.Eur J Clin Pharmacol. 1982;23(6):483-9. doi: 10.1007/BF00637493. Eur J Clin Pharmacol. 1982. PMID: 7160416
-
Minoxidil in the management of moderate hypertension.J Cardiovasc Pharmacol. 1980;2 Suppl 2:S242-6. doi: 10.1097/00005344-198000022-00019. J Cardiovasc Pharmacol. 1980. PMID: 6156361 Clinical Trial.
-
Minoxidil.Ann Intern Med. 1981 Jan;94(1):61-5. doi: 10.7326/0003-4819-94-1-61. Ann Intern Med. 1981. PMID: 6108737 Review.
-
Clinical experience of long-term treatment with minoxidil in severe arterial hypertension.Scand J Urol Nephrol. 1982;16(1):57-63. doi: 10.3109/00365598209179641. Scand J Urol Nephrol. 1982. PMID: 7089494
-
Minoxidil therapy in refractory hypertension analysis of 155 patients.Nephron. 1978;21(1):1-15. doi: 10.1159/000181366. Nephron. 1978. PMID: 351447 Review. No abstract available.
Cited by
-
Chronic treatment with the new potent vasodilator Ro 12-4713 in moderate to severe hypertension: effects on blood pressure, endocrine function, sodium and plasma volume.Eur J Clin Pharmacol. 1981;20(2):79-84. doi: 10.1007/BF00607141. Eur J Clin Pharmacol. 1981. PMID: 7262177
-
Comparative evaluation of the new vasodilator carprazidil and minoxidil in the treatment of moderate to severe hypertension.Eur J Clin Pharmacol. 1982;23(6):483-9. doi: 10.1007/BF00637493. Eur J Clin Pharmacol. 1982. PMID: 7160416
-
Catecholamines, renin, aldosterone, and blood volume during chronic minoxidil therapy.Klin Wochenschr. 1981 Nov 16;59(22):1231-6. doi: 10.1007/BF01747754. Klin Wochenschr. 1981. PMID: 6796750
-
Dietary and pharmacological modification of the insulin/IGF-1 system: exploiting the full repertoire against cancer.Oncogenesis. 2016 Feb 15;5(2):e193. doi: 10.1038/oncsis.2016.2. Oncogenesis. 2016. PMID: 26878387 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical